Intellectual Property

Angiologix’ proprietary technologies and software algorithms are based on cutting-edge research in the area of cardiovascular medicine and are protected by pending US patent and international patents. The technologies stem from years of research at one of the leading universities in Russia. The company has also licensed two US issued patents from a university in the US.